Reliq Health Technologies Inc V.RHT.H

Alternate Symbol(s): RQHTF

Healthcare Medical Devices

Reliq Health Technologies Inc. is a global healthcare technology company that specializes in developing virtual care solutions for the healthcare market. The Company’s iUGO Care platform supports care coordination and community-based virtual healthcare. iUGO Care allows complex patients to receive care at home, improving health outcomes, enhancing quality of life for patients and families and reducing the cost of care delivery. iUGO Care provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent hospital readmissions and ER visits. The iUGO Care platform integrates wearables, sensors, voice technology and mobile apps and desktop user interfaces for patients, clinicians and healthcare administrators. The iUGO Care platform provides services, such as remote patient monitoring, chronic care management, principal care management, behavioral health integration, telemedicine, transitional care management, wound care, and others.

TSXV:RHT.H - Post by User

Reliq Health Technologies Inc

Bullboard Posts

Comment by Aei773ouon Jun 02, 2020 9:48pm

120 Views

Post# 31104523

RE:RE:RE:RE:reply from IR on incoming fast onboarding

The focus is on the wording - met prior guidance of the no. of patients onboard by the end of the calendar year. There no such thing on on-board numbers as prior “guidance”, only “expectation”, implying a projection.The prior guidance is on revenue growth of 100% then 50% - 100% then steady growth. Now this IR reply changes guidance directing to the number of patients. And I personally think is a mix-up without clarity. I maintain they really imply if they are to start now there is a chance to onboard the majority of patients in the big contracts, but just a “if”. The question is when can they start? They probably don’t know. All discussions so far is of inconsequential.

digitel wrote: "Something tells me mgmt conveniently changes the rules to avoid bad news."

Revenue guidance shouldn't be given by early-stage development companies until process is figured out and there are multiple contracts and revenue has demonstrated a linear predictability. RHT had a lot of pressure put on its based upon the size of the deals and potential and provided dramatic guidance which it couldn't be certain of. It has now removed the spectacual guidance and is positioned to exceed expectations.

From the claim of profitability expected this year, to the timeline for the onboarding of large clients to the claim they really do see themselves catching up to Livongo rather quickly much expectation is still there but there is no specific revenue target that the market can get overworked about as RHT works through the kinks, establishes traction and matures past this difficult to predict early development stage.